Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5011)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 27, 2022 (publication date) through Dec 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang S, Zhong BY, Zhang L, Wang WS, Ni CF. Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition. World J Gastrointest Surg 2022; 14(6): 528-537 [PMID: 35979416 DOI: 10.4240/wjgs.v14.i6.528] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i6/528.htm |
| Number | Citing Articles |
| 1 |
Arash Najafi. Commentary on “Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness”. CardioVascular and Interventional Radiology 2024; 47(7): 978 doi: 10.1007/s00270-024-03794-x
|
| 2 |
Landon L. Chan, Stephen L. Chan. The evolving role of lenvatinib at the new era of first-line hepatocellular carcinoma treatment. Clinical and Molecular Hepatology 2023; 29(4): 909 doi: 10.3350/cmh.2023.0114
|
| 3 |
Xiao-Bo Cheng, Li Yang, Ming-Qian Lu, Yi-Bo Peng, Lei Wang, Shuang-Ming Zhu, Zhi-Wei Hu, Zhong-Liang Wang, Qin Yang. Clinical study of different interventional treatments for primary hepatocellular carcinoma based on propensity-score matching. World Journal of Gastrointestinal Surgery 2024; 16(11): 3463-3470 doi: 10.4240/wjgs.v16.i11.3463
|
| 4 |
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
|
| 5 |
Xinhao Wang, Yefa Yang. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases. Medicine 2024; 103(20): e38174 doi: 10.1097/MD.0000000000038174
|
| 6 |
Amit G. Singal, Fasiha Kanwal, Josep M. Llovet. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nature Reviews Clinical Oncology 2023; 20(12): 864 doi: 10.1038/s41571-023-00825-3
|
| 7 |
Liyan Huang, Qinqin Long, Qunying Su, Xiaoying Zhu, Xidai Long. Aflatoxin B1-DNA adducts modify the effects of post-operative adjuvant transarterial chemoembolization improving hepatocellular carcinoma prognosis. Exploration of Targeted Anti-tumor Therapy 2023; : 780 doi: 10.37349/etat.2023.00167
|
| 8 |
Long-Wang Lin, Kun Ke, Le-Ye Yan, Rong Chen, Jing-Yao Huang. Efficacy and safety of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors plus programmed death-1 inhibitors for hepatocellular carcinoma refractory to transarterial chemoembolization. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1178428
|